Zoetis issues update on rotavirus vaccines
Zoetis will continue to supply an alternative equine rotavirus vaccine until normal supply of Equip Rotavirus can be restored.
Animal health firm Zoetis has confirmed that it will continue to supply an alternative equine rotavirus vaccine until normal supply of the unique licensed product Equip Rotavirus can be restored.
The organisation said in a press release that it will extend distribution of the alternative rotavirus vaccine under a Wholesale Dealer Import Certificate. The next batch of the Equip Rotavirus, however, will not be available before March 2019.
‘Practices wishing to purchase the alternative imported rotavirus vaccine will need to apply to the VMD for a Special Treatment Certificate (STC) for batch numbers 269174A and 296081A and order through their wholesaler,’ said a spokesperson for Zoetis.
‘Zoetis acknowledges the concern and frustration this causes their customers, reassures the equine community that they are working diligently to resume Equip Rotavirus supply as soon as possible and apologises for any convenience caused.’
The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.
